Effectiveness of inhaled treprostinil versus standard of care for the treatment of pulmonary hypertension associated with interstitial lung disease: A propensity score-weighted study of the INCREASE trial and registry data from Europe

First published 05/07/2024

Last updated 10/09/2024

EU PAS number:

EUPAS1000000238

Study

Planned

Documents

Study protocol

Initial protocol

Ferrer_TYVASO_HTA_ECA_protocol_v1.0.pdf

English (11.24 MB - PDF)View document

Updated protocol

Ferrer_TYVASO_HTA_ECA_Protocol v2.0_FULLY SIGNED 31Aug2024 HMA.pdf

First published: 03/09/2024

English (2.13 MB - PDF)View document

Study results

Study report

Other information

Secondary tabs